La Roche-Posay "Blue Ribbon" Summit Promised to Improve Skin Issues of Cancer Patients
- Chaileedo Press
- May 26, 2022
- 3 min read
On the evening of May 25th, BST, La Roche-Posay, an active health skin care brand under L'Oreal Group, launched the“Blue Ribbon”project to care for the skin health of cancer patients, aiming to call more people to pay attention to the skin health problems of cancer patients during the treatment process.
"Patients in the past just wanted to live, and later patients wanted to live a comfortable life. Now, more and more people want to live a good life," said a head nurse from a top-grade tertiary hospital in China. Traditional tumor treatment lacks attention to the adverse reactions of patients, but today, when more and more patients are beginning to have a chance of long-term survival, reducing adverse reactions and improving the quality of life may become a topic of increasing concern.
La Roche-Posay has been deeply engaged in scientific research in the field of Dermatology and has conducted in-depth cooperation with dermatology experts all over the world. This time, La Roche-Posay invited experts and scholars in the two fields of cancer and skin, including Professor Cheng Ying from Jilin Cancer Hospital, Professor Xiang Leihong from Huashan Hospital of Fudan University, as well as HUGUET Claire from Medical Director of L'Oreal North Asia and KEROB Delphine, the scientific director of La Roche-Posay's global laboratory, to gather in the cloud with consumers, to share the latest trends of La Roche-Posay, and to explore the knowledge of skin care in depth.
At this forum, La Roche-Posay released the first "Investigation and Research Report on Current Situation of Skin Adverse Reactions in Chinese Cancer Clinical Diagnosis and Treatment" 1. And a total of 221 valid questionnaires from doctors and 220 patients were obtained in the survey. The survey shows that in the clinical treatment of tumors, nearly half of the patients had skin adverse reactions due to radiotherapy; 38.9% had skin adverse reactions due to chemotherapy drugs; A few patients had adverse skin reactions due to endocrine therapy and traditional Chinese medicine treatment.
Adverse reactions in the clinical diagnosis and treatment of tumors can affect all organs of the human body, and the skin is a high-risk site. Although the skin will not affect the safety of life, it will cause the patient's appearance to change and cause negative emotions such as inferiority complex and disgust, which is not conducive to the patient's rehabilitation.
“Prevention is more important for tumor patients. In terms of primary prevention, it is recommended to use mild and clean skin care products, followed by a reasonable moisturizing to help repair the skin barrier.” Professor Xiang Leihong suggested. “To prevent tumors, sun protection is also a very important procedure. Sun protection products can prevent the appearance and aggravation of rashes. It is recommended that patients use some broad-spectrum sunscreens that can fight against UVB and UVA, with an SPF 30+, PA++ or above.”
In this forum, in addition to discussing the prevention, treatment and treatment of adverse skin reactions related to tumor treatment. It was also mentioned that La Roche-Posay products can improve skin adverse reactions in the clinical diagnosis and treatment of tumors. KEROB Delphine said that among 107 female breast cancer patients who had received chemotherapy, 80% of the patients had improved skin conditions after using La Roche-Posay products. ; 64% of patients have improved quality of life.
With technology empowering products, B5 Soothing and Repairing Balm is a popular product of La Roche-Posay, with 0% essence, lanolin, steroids, etc. added, having an actual effect in promoting collagen synthesis and accelerating skin barrier repair. HUGUET Claire said at the forum that in 2022, after more than 3 years of research, La Roche-Posay completed the first clinical study on La Roche-Posay B5 Soothing and Repairing Balm, which proved its curative effect on skin adverse reactions related to tumor treatment, improving the quality of life of patients effect.
It is worth mentioning that in February this year, La Roche-Posay's "Blue Ribbon" project to care for the skin health of cancer patients was officially launched in China. In March, La Roche-Posay sent the first batch of loving products to patients and their families in Shanghai. It donated 3,000 copies of La Roche-Posay B5 Soothing and Repairing Balm and 1,500 copies of soothing spray. This time, La Roche-Posay also donated 2,000 skin care packages to Beijing Love Book Cancer Foundation for cancer patients.
La Roche-Posay's "Blue Ribbon" project aims to appeal to more people to care for the skin health problems encountered by patients during treatment. HUGUET Claire mentioned that before 2025, La Roche-Posay hopes to raise awareness of adverse skin reactions related to tumor treatment and improve the quality of life of cancer patients through the "Fight with care" tumor program. La Roche-Posay hopes that 1 billion people will know about this project and plans to train 1 million people to support cancer patients in need.
Comentarios